Abstract

PICHARDO-RODRIGUEZ, Rafael et al. Concurrence between Guillain-Barré syndrome and immune thrombocytopenic purpura possibly induced by long COVID-19. Rev. perú. med. exp. salud publica [online]. 2022, vol.39, n.1, pp.111-114.  Epub Mar 31, 2022. ISSN 1726-4634.  http://dx.doi.org/10.17843/rpmesp.2022.391.10687.

During acute SARS-CoV-2 infection, there is persistent deregulation of the immune system that can last up to 8 months after the acute condition is controlled. This, added to other factors, is possibly associated with an increased risk of the appearance and concurrence of autoimmune diseases. The simultaneous occurrence of GBS and ITP has been rarely reported in the literature, and GBS is rarely associated with another autoimmune disease. We present the case of a man who, one month after his recovery from acute moderate COVID-19, presented concurrent GBS and ITP with an adequate response to treatment.

Keywords : Guillain-Barre Syndrome; Purpura Thrombocytopenic Idiopathic; COVID-19; autoimmunity; Autoimmune diseases; Autoimmune Diseases of the Nervous System; Autoimmune Demyelinating Diseases CNS; Blood Platelet Disorders; thrombocytopenia; SARS-CoV-2.

        · abstract in Spanish     · text in English | Spanish     · English ( pdf ) | Spanish ( pdf )